Immune reconstitution therapies are reshaping modern MS management, offering periods of lasting disease control without continuous immunosuppression. In this thought-provoking session, Prof. Patrick Vermersch, leading MS clinician and clinical trial expert, examines how IRTs work in real clinical practice, what drives long-term success, and how to navigate risks, patient selection, and treatment timing.
Drawing on decades of research and clinical experience, Prof. Vermersch provides a clear and clinically meaningful framework for understanding cladribine, alemtuzumab, HSCT, and other...
In this educational session, Prof. Celia Oreja-Guevara explores the crucial role of microglia in multiple sclerosis and how our evolving understanding of these resident immune cells is reshaping approaches to disease monitoring and treatment. Professor Oreja-Guevara discusses how microglial activation contributes to lesion development, chronic inflammation, and disability progression, while highlighting emerging therapeutic strategies targeting neuroinflammation.
With clear clinical relevance and a forward-looking perspective, this presentation is ideal for neurologists and clinicians interested...
This on-demand webinar is accredited via EACCME. You will receive a certificate for 1 European CME credit upon watching the webinar in full and successfully completing an exam.
Please register in order to get free access to the webinar here.
After you have watched the recorder webinar, you can complete the exam here.
Your certificate will be sent to you in the 72 hours following the completion of the exam. Should you not receive it, or need any further information, please contact: secretariat@paradigms.foundation
The webinar on ‘Risks, pregnancy, vaccination...
30th June 2022, Seventh ParadigMS Symposium
During the Seventh Belgian ParadigMS Symposium, Prof Celia Oreja-Guevara and Prof Veronica Popescu had a workshop on MRI & OCT.
This video interview with Prof Veronica Popescu is based on the workshop on MRI & OCT. Consult here the video interview.
.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }
ABSTRACT
By the end of this workshop...
24th April 2021, Expert Meeting. This video interview with Bart Van Wijmeersch is based on the slide deck “Individualized Prognosis in MS” by Celia Oreja-Guevara & Bart Van Wijmeersch and brings out the key points.
.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }
ABSTRACT
This video interview with Bart Van Wijmeersch is based on the slide deck “Individualized...
24 April 2021, Expert meeting. : How is an MS patient’s disease likely to progress over time? Will the patient be stable on a first-line therapy, or will the disease progress quickly if not treated aggressively? Professors Bart Van Wijmeersch and Celia Oreja-Guevara share with you their wealth of experience concerning patient prognosis.
Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material.
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately.
ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.
Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.
Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.